Transcelerate Biopharma Inc

“The members of the corporation consist of such firms and corporations that are approved for membership from time to time by the board of directors or its designees in accordance with the policies and procedures of the corporation. The corporation has the following categories of members: a. Tier i members - to be eligible for tier i membership, a firm or corporation must be a pharmaceutical or biotechnology company with an annual budget for research and development in excess of $2.5 billion. Eligibility for tier i membership is established based upon a company's publically available research and development expenditures over the three (3) year period preceding the date the company applies to join the corporation. The initial tier i members are further defined as the "charter members." b. Tier ii members - to be eligible for tier ii membership, a firm or corporation must be a pharmaceutical or biotechnology company with an annual budget for research and development that is less than $2.5 billion but more than $100 million. Eligibility for tier ii membership will be established based upon a company's publically available research and development expenditures over the three (3) year period preceding the date the company applies to join the corporation. C. Associate members - to be eligible for associate membership, a firm or corporation must be a pharmaceutical or biotechnology company with an annual budget for research and development that is less than $100 million or be an external partner of pharmaceutical companies in clinical trials.”

“The board of directors shall be comprised of up to twenty (20) members; provided that: (i) ten (10) seats are filled by directors who are representatives of the charter members; (ii) up to two (2) additional seats shall be filled by directors who are representatives of the tier i members who are not charter members; (iii) up to six (6) seats shall be filled by directors who are representatives of the tier ii members; (iv) one (1) seat shall be filled by a director who is a representative of the associate members; and (v) one (1) seat shall be filled by the chief executive officer of the corporation. The corporation's bylaws state that directors shall be elected or appointed, as applicable, annually at the annual meeting of members and shall serve until the following annual meeting of members and until their successors are elected or appointed, as applicable, and qualified. Each charter member shall have the right to appoint a representative of the charter member to serve as a charter member director. Tier i directors shall be elected by a plurality vote of the tier i members, which include the charter members. Tier ii directors shall be elected by a plurality vote of the tier ii members. The associate member director shall be elected by a plurality vote of the associate members. The ceo director shall serve ex-officio, for so long as he or she shall hold the office of chief executive officer. Each tier i member shall be entitled to three (3) votes at every meeting of members on matters which tier 1 members are entitled to vote. Each tier ii member shall be entitled to one (1) vote at every meeting of members on matters which tier ii members are entitled to vote. Associate members shall be entitled to notice of and to attend meetings of the members but shall not be entitled to vote at such meetings, provided however, associate members shall have the right to cast one (1) vote each with respect to the election of the nominee to fill the associate member board position. Notwithstanding the above, in order to be eligible to vote, a member must be in good standing and its dues and assessments paid in full.”

“The finance committee and management review and approve the form 990. The form is then distributed to all members of the board for their review before filing with the internal revenue service.”

“The transcelerate executive committee prepares and approves the compensation package for the ceo. The ceo approves the compensation for the senior vice president of global operations, along with all other key employees.”

“The organization's governing documents, financial statements, and conflict of interest policy are available upon request.”

“The organization plans to develop and adopt a written document retention and destruction policy in the future.”

“Outside contract - technology consulting services: program service expenses 2,315,875. Management and general expenses 19,830. Fundraising expenses 0. Total expenses 2,335,705. Consultants -technology consulting services: program service expenses 3,623,602. Management and general expenses 354,883. Fundraising expenses 0. Total expenses 3,978,485. Cross ws fees: program service expenses 1,473,061. Management and general expenses 0. Fundraising expenses 0. Total expenses 1,473,061. Marketing consultant - outside consultant: program service expenses 13,500. Management and general expenses 410,350. Fundraising expenses 0. Total expenses 423,850.”